REMS For Opioids, LABAs May Be Driven By PBM "Feedback" Mechanism
This article was originally published in The Pink Sheet Daily
Executive Summary
Possible contract from FDA would involve assessing whether PBM distribution of safety information to physicians would change prescribing practices.
You may also be interested in...
Opioid REMS Could Be Linked To CME, FDA Suggests
Advisory committee panel members will weigh in on the value of common educational materials and the metrics for success.
Opioid REMS Could Be Linked To CME, FDA Suggests
Advisory committee panel members will weigh in on the value of common educational materials and the metrics for success.
Sponsors Will Need New Databases And Metrics To Determine Success Of Opioids REMS
FDA sees REMS assessment as a collaborative effort and already has initiatives with other federal agencies to find ways to monitor indicators of effectiveness.